2m 2m 2m 2m 2m 2m 2m
Cellectis Sp ADR (CLLS)
NASDAQ
$3.11-$0.27 (-7.99%)
Price as of Jun 03, 2026 7:14 PM EDT- $255.6MMarket Cap
- 131.51%1-Year Change
- BiotechnologyIndustry
Cellectis Sp ADR (CLLS)
$3.11-$0.27 (-7.99%)
CLLS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.38 | ||
Change | -$0.10 (-2.87%) | ||
Open | $3.43 | ||
High | $3.49 | ||
Low | $3.35 | ||
Previous Close | $3.48 | ||
Volume | 46,857 | ||
30-Day Average Volume | 31,930 | ||
1-Week Change | -7.90% | ||
1-Month Change | -14.43% | ||
1-Year Change | 131.51% | ||
3-Year Change | 69.85% | ||
5-Year Change | -77.76% | ||
Fundamentals | |||
Shares Outstanding | 72.6M | ||
Total Assets | $324.7M | ||
Market Cap | $255.6M | ||
Enterprise Value | $194.1M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue